Controlled Attenuation Parameter News Today

Recently, Fibroscan has incorporated the noninvasive Controlled Attenuation Parameter technique to estimate the degree of fatty infiltration in the liver.

Lanifibranor 800mg achieved the primary efficacy endpoint demonstrating a 44% reduction of hepatic fat measured by proton magnetic resonance spectroscopy (1H-MRS) following 24 weeks of treatment in patients

Five poster presentations showing: the correlation between the improvement of hepatic steatosis and a robust increase in adiponectin levels, improvement in lipid profile and glycemic control in patients

FinancialContent fully hosted finance channel

Researchers determined the contribution of ultra-processed food intake to the risk of developing NAFLD.

Investegate announcements from INVENTIVA,  Inventiva announces the presentation of a scientific abstract at the next International Conference on Fatty Liver

Daix (France), Long Island City (New York, United States), April 7, 2022 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small

Investegate announcements from INVENTIVA, Inventiva to host a webcast with Key Opinion Leaders from the AASLD The Liver Meeting™ 2021  

Investegate announcements from INVENTIVA, Inventiva announces the presentation of five scientific abstracts at the AASLD The Liver Meeting™ 2021

Fatty Liver Can Damage Heart, Say Scientists by Angela Mohan on  May 3, 2021 at 9:07 AM Fatty Liver increase the risk of heart disease by four times compared to people of the same age and sex who had normal livers. Japanese and European scientists were the first to report this finding and their observations are proving true across the world. Using sophisticated techniques, doctors have found the wall of arteries to be thicker and the lumen narrower, causing reduced flow of b...